Reich D L, Hammerschlag B C, Rand J H, Perucho-Powell M H, Thys D M
Department of Anesthesiology, Mount Sinai Medical Center, New York, NY.
J Cardiothorac Vasc Anesth. 1992 Dec;6(6):677-9. doi: 10.1016/1053-0770(92)90050-h.
The results of a prior clinical report suggested that nitroglycerin may interfere with the anticoagulant effect of heparin. Therefore, 30 adult patients undergoing cardiac surgery were studied in a controlled, prospective fashion. Thirteen patients on chronic nitrate therapy received an intraoperative nitroglycerin infusion at 1 micrograms/kg/min intravenously. Seventeen patients received no preoperative or intraoperative nitrates (control group). Heparin, 300 units/kg, was administered to all patients in three consecutive doses: 40 units/kg, 80 units/kg, and 180 units/kg. The activated coagulation time and activated partial thromboplastin time were measured prior to heparin, and 5 minutes after each heparin dose. There were no differences in automated activated coagulation times or in activated partial thromboplastin times between the groups at any measurement period. The study is limited in that only patients on chronic nitrates were included in the treatment group and that only a modest dose of nitroglycerin was used. However, it is concluded that a modest dose of intravenous nitroglycerin does not interfere with the anticoagulant effect of boluses of beef lung heparin in patients undergoing cardiac surgery.
先前一份临床报告的结果表明,硝酸甘油可能会干扰肝素的抗凝作用。因此,对30例接受心脏手术的成年患者进行了一项对照性前瞻性研究。13例接受慢性硝酸盐治疗的患者术中以1微克/千克/分钟的速度静脉输注硝酸甘油。17例患者术前或术中未接受硝酸盐治疗(对照组)。所有患者均连续三次给予300单位/千克的肝素:40单位/千克、80单位/千克和180单位/千克。在给予肝素前以及每次给予肝素后5分钟测量活化凝血时间和活化部分凝血活酶时间。在任何测量时间段,两组之间的自动活化凝血时间或活化部分凝血活酶时间均无差异。该研究的局限性在于,治疗组仅纳入了接受慢性硝酸盐治疗的患者,且仅使用了小剂量的硝酸甘油。然而,得出的结论是,小剂量静脉输注硝酸甘油不会干扰接受心脏手术患者使用大剂量牛肺肝素的抗凝效果。